Douglas Krulik - 26 Jun 2026 Form 4/A - Amendment Insider Report for PETMED EXPRESS INC (PETS)

Reporting relationship: CAO and Interim CFO
Issuer ticker: PETS
Reported as of: 26 Jun 2026
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 24 Jul 2026, 16:32:43 UTC
Original report date: 26 Jun 2026
Prior SEC filing: 03 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Douglas Krulik

Key filing fact

Douglas Krulik filed Form 4/A - Amendment for PETMED EXPRESS INC (PETS) on 24 Jul 2026.

Key facts

This page summarizes Douglas Krulik's Form 4/A - Amendment filing for PETMED EXPRESS INC (PETS).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 24 Jul 2026, 16:32.

Change

Previous filing in this sequence was filed on 03 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0002035815 Primary reporting owner

KRULIK DOUGLAS

Relationship: CAO and Interim CFO
Address: C/O PETMED EXPRESS, INC., 420 SOUTH CONGRESS AVENUE, DELRAY BEACH
Signature: /s/ Douglas Krulik
Signature date: 26 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PETS transaction

Common Stock

Award

Transaction value
Shares: +32,500
Change %: +46%
Price: $0.000000^*
Shares after: 102,500
Date: 26 Jun 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PETS transaction Derivative

Performance Share Units

Award

Transaction value
Shares: +32,500
Change %
Price: $0.000000^*
Shares after: 32,500
Date: 26 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 32,500
Exercise price
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to 50% of granted shares on June 26, 2027, and 50% on June 26, 2028, subject to continued employment through each such vesting date.

Footnote F2

Performance Share Units ("PSUs") granted pursuant to the 2024 Omnibus Incentive Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a two-year performance period beginning on April 1, 2026 ending on March 31, 2028.

SEC remarks

Explanatory Note: This Amended Form 4 is being filed solely to make a correction to the description of the performance period in Footnote 2 of the originally filed Form 4 filed on June 26, 2026, and to correspondingly revise the Expiration Date in Table II of the originally filed Form 4. No other changes were made to the originally filed Form 4.